2017
DOI: 10.1111/bjd.15308
|View full text |Cite|
|
Sign up to set email alerts
|

Sixteen novel mutations in PNPLA1 in patients with autosomal recessive congenital ichthyosis reveal the importance of an extended patatin domain in PNPLA1 that is essential for proper human skin barrier function

Abstract: We estimate the frequency of PNPLA1 mutations among patients with ARCI to be around 3%. Most of our patients were born as collodion babies and showed a relatively mild ichthyosis phenotype. In four unrelated patients we observed a cyclic scaling course, which seems to be a potential phenotypic variation in a small percentage of patients with PNPLA1 mutations. The variability of the clinical manifestations and the lack of typical clinical features are specific for patients with PNPLA1 mutations, and emphasize t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

4
29
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 28 publications
(33 citation statements)
references
References 21 publications
4
29
0
Order By: Relevance
“…In this issue of the BJD , Zimmer et al . report 16 novel mutations in PNPLA1 in patients with ARCI as a result of screening > 700 families with ichthyosis, thus suggesting that the frequency of PNPLA1 mutations among all patients with ARCI is around 3% . These findings complement a recent publication which also reported six novel mutations in PNPLA1 in nine extended consanguineous families in a cohort of 92 families .…”
supporting
confidence: 79%
“…In this issue of the BJD , Zimmer et al . report 16 novel mutations in PNPLA1 in patients with ARCI as a result of screening > 700 families with ichthyosis, thus suggesting that the frequency of PNPLA1 mutations among all patients with ARCI is around 3% . These findings complement a recent publication which also reported six novel mutations in PNPLA1 in nine extended consanguineous families in a cohort of 92 families .…”
supporting
confidence: 79%
“…[21][22][23] To date, 26 different PNPLA1 mutations have been reported associated with ARCI. 17,[24][25][26][27]30 In the present study, we report two novel mutations, including one missense mutation c.335C>A (p.Ser112Tyr) and one deletion mutation c.733_735delTAC (p.Tyr245del), and also one previously reported missense mutation c.514G>A (p.Asp172Asn) in PNPLA1 gene in seven ARCI patients from three consanguineous Turkish families.…”
supporting
confidence: 56%
“…Clinical findings of our ARCI patients were commonly similar to previously reported symptoms. 25 Generally, the symptoms of ARCI patients with PNPLA1 mutations are relatively milder than the other forms of ARCI especially caused by TGM1 and ABCA12 mutations. 25 ARCI causing genes play important roles in differentiation of epidermal keratinocytes and/or formation of epidermal lipid barrier.…”
Section: Discussionmentioning
confidence: 98%
“…In some populations, PNPLA1 and CERS3 mutations are very rare, while in our Iranian cohort, PNPLA1 was the second most common mutated gene accounting for 19 of the 125 ARCI families (15.2%). Additional families with PNPLA1 mutations have also recently been reported, attesting to the increasing recognition of the prevalence of mutations in this gene (Boyden et al., ; Zimmer et al., ). A unique aspect of our cohort is that 90% of cases come from consanguineous families, as evidenced by the fact that 102 of the 106 cases (96.2%) with pathogenic mutations were homozygous for the variant.…”
Section: Discussionmentioning
confidence: 96%